Strategic Analysis of the Clinical Research Organization Market in India

Strategic Analysis of the Clinical Research Organization Market in India

Defining the Future of R&D

RELEASE DATE
03-Jul-2012
REGION
Asia Pacific
Research Code: P5E8-01-00-00-00
SKU: HC02367-AP-MR_08487
AvailableYesPDF Download

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC02367-AP-MR_08487

$4,950.00

$3,712.50save 25 %

DownloadLink
ENQUIRE NOW

Description

This research deliverable provides detailed insights into the clinical development and outsourcing market of India. It also includes an overview of the Indian regulatory and R&D process briefing. It describes the Clinical trials scenario today at a therapeutic level of focus. Furthermore, it highlights the key trends, drivers, restraints and also the challenges faced by the clinical research market today. The research deliverable also covers the forecast of the CRO market from 2010 to 2016. The research service also gives a deeper insight, not only into the phase-wise, but also therapy-wise details of the clinical trials. An understanding of increasing R&D expenditures by different pharmaceutical companies is also given.

Table of Contents

Brief Summary of the Clinical Trials in India

  • Indian CRO Market: Overview
  • Dynamics of the Indian CRO Market 2011-2016
  • Opportunities and Deterrents in the Indian CRO Market and their Impact

Regulatory Overview in Conducting Clinical Trials in India

  • Overview of the Clinical Trials Market in India
  • Trends in Regional and Local Pharmaceutical and Biotechnology Development
  • Indian Regulatory Environment
  • Clinical Trial Registration Process
  • Indian Regulatory Environment: Developments
  • Indian Regulatory Environment – Impact of Developments

Clinical Trials Profile: India

  • Clinical Trials
  • Profile of Clinical Trials
  • Breakdown of Clinical Trials by Therapeutic Focus

Market Analysis

  • Market Engineering Measurements
  • Industry Challenges
  • Market Drivers Ranked in Order of Impact
  • Market Restraints Ranked in Order of Impact
  • Revenue Forecast
  • Competitive Structure
  • Market Share Analysis of Leading CROs
  • Profile of CRO Company - Quintiles
  • Profile of CRO Company: ICON Clinical Research
  • Profile of CRO Company: SIRO Clinpharm
  • Profile of CRO Company: PPD India
  • Profile of CRO Company: Parexel India
  • Profile of CRO Company: Diagnosearch
  • Profile of CRO Company: Clinigene International Ltd.
  • Profile of CRO Company: Asian Clinical Trials
  • Profile of CRO Company: Sristek
  • Percent of Revenue of CROs by Sponsor Type

Demand Side Overview of the Indian CRO Market

  • Pharmaceutical R&D Expenditure Forecast
  • Percent of Pharmaceutical R&D Budget Allocation for CROs by Companies Surveyed
  • Percent of R&D Expenditure by Type of Trial
  • Summary of R&D Activities Outsourced by Phase
  • Data Capture and Management Needs of Local and Multinational Companies
  • Goals in Outsourcing Clinical Trials
  • CRO Selection Criteria for International Trials
  • CRO Selection Criteria for Local Trials
  • Multinational versus Local CROs
  • Preferred Geographical Areas for Outsourcing Services
  • Key Stages and the Corresponding Personnel Involved in the Outsourcing Decision-making Process

Conclusions

  • Challenges Faced by CROs
  • Future Trends
  • Conclusion and Recommendations
Related Research
This research deliverable provides detailed insights into the clinical development and outsourcing market of India. It also includes an overview of the Indian regulatory and R&D process briefing. It describes the Clinical trials scenario today at a therapeutic level of focus. Furthermore, it highlights the key trends, drivers, restraints and also the challenges faced by the clinical research market today. The research deliverable also covers the forecast of the CRO market from 2010 to 2016. The research service also gives a deeper insight, not only into the phase-wise, but also therapy-wise details of the clinical trials. An understanding of increasing R&D expenditures by different pharmaceutical companies is also given.
More Information
No Index No
Podcast No
Industries Healthcare
WIP Number P5E8-01-00-00-00
Is Prebook No